Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

When he was 10 and newly diagnosed with diabetes, Julian “Yudi” Rubin and his mother were told he wouldn’t live past 30 and wouldn’t be able to father children. He’ll be 90 this spring, an occasion he ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

Researchers at The University of Colorado Anschutz Medical Campus and colleagues at Massachusetts General Hospital, have found that people with diabetes can achieve the same positive results using ...

Red ginseng extract powder significantly improved glycemic control in prediabetic Korean adults over 12 weeks without adverse ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...